97-22570. Manufacturer of Controlled Substances; Notice of Regulation

[Federal Register Volume 62, Number 165 (Tuesday, August 26, 1997)]
[Notices]
[Page 45274]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-22570]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Regulation

    By Notice dated March 31, 1997, and published in the Federal 
Register on May 8, 1997, (62 FR 25211), Roche Diagnostic Systems, Inc., 
1080 U.S. Highway 202, Somerville, New Jersey 08876-3771, made 
application by renewal to the Drug Enforcement Administration (DEA) to 
be registered as a bulk manufacturer of the basic classes of controlled 
substances listed below:

------------------------------------------------------------------------
                    Drug                               Schedule         
------------------------------------------------------------------------
Lysergic acid diethylamide (7315)..........  I                          
Tetrahydrocannabinols (7370)...............  I                          
Phencyclidine (7471).......................  II                         
Methadone (9250)...........................  II                         
Morphine (9300)............................  II                         
------------------------------------------------------------------------

    DEA has considered the factors in Title 21, United States Code, 
Section 823(a) and determined that the registration of Roche Diagnostic 
Systems, Inc. to manufacture the listed controlled substances is 
consistent with the public interest at this time. Therefore, pursuant 
to 21 U.S.C. Sec. 823 and 28 C.F.R. Secs. 0.100 and 0.104, the Deputy 
Assistant Administrator, Office of Diversion Control, hereby orders 
that the application submitted by the above firm for registration as a 
bulk manufacturer of the basic classes of controlled substances listed 
above is granted.

    Dated: July 29, 1997.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 97-22570 Filed 8-25-97; 8:45 am]
BILLING CODE 4410-09-M